| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected and Quantified |
|---|
| Creation Date | 2006-08-15 20:10:24 UTC |
|---|
| Update Date | 2022-03-07 02:49:02 UTC |
|---|
| HMDB ID | HMDB0000492 |
|---|
| Secondary Accession Numbers | - HMDB0002073
- HMDB00492
- HMDB02073
|
|---|
| Metabolite Identification |
|---|
| Common Name | Chloride ion |
|---|
| Description | Under standard conditions, chlorine exists as a diatomic molecule. Chlorine is a highly toxic, pale yellow-green gas that has a specific strong smell. In nature, chlorine is most abundant as a chloride ion. Physiologically, it exists as an ion in the body. The chloride ion is an essential anion that the body needs for many critical functions. It also helps keep the body's acid-base balance. The amount of chloride in the blood is carefully controlled by the kidneys. Chloride ions have important physiological roles. For instance, in the central nervous system, the inhibitory action of glycine and some of the action of GABA relies on the entry of Cl- into specific neurons. Also, the chloride-bicarbonate exchanger biological transport protein relies on the chloride ion to increase the blood's capacity of carbon dioxide, in the form of the bicarbonate ion. Chloride-transporting proteins (CLC) play fundamental roles in many tissues in the plasma membrane as well as in intracellular membranes. CLC proteins form a gene family that comprises nine members in mammals, at least four of which are involved in human genetic diseases. GABA(A) receptors are pentameric complexes that function as ligand-gated chloride ion channels. WNK kinases are a family of serine-threonine kinases that have been shown to play an essential role in the regulation of electrolyte homeostasis, and they are found in diverse epithelia throughout the body that are involved in chloride ion flux. Cystic fibrosis (CF) is caused by alterations in the CF transmembrane conductance regulator (CFTCR) gene that result in deranged sodium and chloride ion transport channels. (PMID: 17539703 , 17729441 , 17562499 , 15300163 ) (For a complete review see Evans, Richard B. Chlorine: state of the art. Lung (2005), 183(3), 151-167. PMID: 16078037 ). |
|---|
| Structure | |
|---|
| Synonyms | | Value | Source |
|---|
| Chloride(1-) | ChEBI | | Chlorine anion | ChEBI | | CL(-) | ChEBI | | Chloride | Kegg | | Bertholite | HMDB | | Chloor | HMDB | | Chlor | HMDB | | Chlore | HMDB | | Chlorine | HMDB | | Chlorine gas | HMDB | | Cl | HMDB | | Cl2 | HMDB | | Diatomic chlorine | HMDB | | Dichlorine | HMDB | | Molecular chlorine | HMDB | | Chloride ion level | HMDB | | Ion level, chloride | HMDB | | Chlorides | HMDB | | Level, chloride ion | HMDB | | MSR-1 Protein, nicotiana plumbaginifolia | HMDB | | PLS216 Protein, nicotiana plumbaginifolia | HMDB |
|
|---|
| Chemical Formula | Cl |
|---|
| Average Molecular Weight | 35.453 |
|---|
| Monoisotopic Molecular Weight | 34.968852707 |
|---|
| IUPAC Name | chloride |
|---|
| Traditional Name | chloride |
|---|
| CAS Registry Number | 16887-00-6 |
|---|
| SMILES | [Cl-] |
|---|
| InChI Identifier | InChI=1S/ClH/h1H/p-1 |
|---|
| InChI Key | VEXZGXHMUGYJMC-UHFFFAOYSA-M |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of inorganic compounds known as homogeneous halogens. These are inorganic non-metallic compounds in which the largest atom is a nobel gas. |
|---|
| Kingdom | Inorganic compounds |
|---|
| Super Class | Homogeneous non-metal compounds |
|---|
| Class | Homogeneous halogens |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Homogeneous halogens |
|---|
| Alternative Parents | Not Available |
|---|
| Substituents | |
|---|
| Molecular Framework | Not Available |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Not Available | Not Available |
|---|
| Physical Properties |
|---|
| State | Liquid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | -101 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 6.3 mg/mL at 25 °C | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Predicted by Siyang on May 30, 2022 | 10.2523 minutes | 33406817 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 289.7 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 866.4 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 420.4 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 187.7 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 347.4 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 207.2 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 312.3 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 398.0 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 625.4 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 638.9 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 154.0 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 738.7 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 283.2 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 370.5 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 688.2 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 354.0 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 309.0 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatized| Metabolite | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Chloride ion | [Cl-] | 692.5 | Standard polar | 33892256 | | Chloride ion | [Cl-] | 241.4 | Standard non polar | 33892256 | | Chloride ion | [Cl-] | 95.8 | Semi standard non polar | 33892256 |
|
|---|
| |
| Blood | Detected and Quantified | 96000 uM | Newborn (0-30 days old) | Male | Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency | | details | | Blood | Detected and Quantified | 84000-100000 uM | Newborn (0-30 days old) | Male | Bartter Syndrome, Type 5, Antenatal, Transient | | details | | Blood | Detected and Quantified | 69900 (53000-88000) uM | Children (1-13 years old) | Both | Congenital chloride diarrhea | | details | | Blood | Detected and Quantified | 108000-115000 uM | Infant (0-1 year old) | Both | Congenital secretory diarrhea | | details | | Blood | Detected and Quantified | 81000-97000 uM | Children (1-13 years old) | Female | Bartter Syndrome, Type 4B, Neonatal, With Sensorineural Deafness | | details | | Blood | Detected and Quantified | 101000 uM | Infant (0-1 year old) | Female | Bartter Syndrome, Type 4B, Neonatal, With Sensorineural Deafness | | details | | Blood | Detected and Quantified | 86000-87000 uM | Newborn (0-30 days old) | Female | Bartter Syndrome, Type 4B, Neonatal, With Sensorineural Deafness | | details | | Blood | Detected and Quantified | 87000 (74000-95000) uM | Children (1-13 years old) | Both | Bartter Syndrome, Type 3 | | details | | Blood | Detected and Quantified | 110000 uM | Adolescent (13-18 years old) | Both | Renal tubular acidosis, distal, RTA type 1 | | details | | Blood | Detected and Quantified | 86000 uM | Newborn (0-30 days old) | Female | Bartter Syndrome, Type 2, Antenatal | | details | | Blood | Detected and Quantified | 84000 uM | Newborn (0-30 days old) | Female | Bartter Syndrome, Type 1, Antenatal | | details | | Blood | Detected and Quantified | 96000-100000 uM | Adult (>18 years old) | Male | Primary Hypomagnesemia | | details | | Blood | Detected and Quantified | 94000-116000 uM | Children (1-13 years old) | Both | Renal tubular acidosis, distal, RTA type 1 | | details | | Blood | Detected and Quantified | 111000-114000 uM | Adult (>18 years old) | Both | Renal tubular acidosis, distal, RTA type 1 | | details | | Blood | Detected and Quantified | 110000-116000 uM | Newborn (0-30 days old) | Both | Renal tubular acidosis, distal, RTA type 1 | | details | | Blood | Detected and Quantified | 102000-140000 uM | Infant (0-1 year old) | Both | Renal tubular acidosis, distal, RTA type 1 | | details | | Sweat | Detected and Quantified | 12800 uM | Children (1-13 years old) | Female | Dibasic Amino Aciduria I | | details | | Urine | Detected and Quantified | 6167.790-7991.801 umol/mmol creatinine | Adult (>18 years old) | Male | Primary Hypomagnesemia | | details | | Urine | Detected and Quantified | 2200-3970 umol/mmol creatinine | Infant (0-1 year old) | Both | Congenital secretory diarrhea | | details |
|
|---|
| Disease References | | Renal tubular acidosis, distal, RTA type 1 |
|---|
- Karet FE, Gainza FJ, Gyory AZ, Unwin RJ, Wrong O, Tanner MJ, Nayir A, Alpay H, Santos F, Hulton SA, Bakkaloglu A, Ozen S, Cunningham MJ, di Pietro A, Walker WG, Lifton RP: Mutations in the chloride-bicarbonate exchanger gene AE1 cause autosomal dominant but not autosomal recessive distal renal tubular acidosis. Proc Natl Acad Sci U S A. 1998 May 26;95(11):6337-42. [PubMed:9600966 ]
| | Primary hypomagnesemia |
|---|
- Jin-no Y, Kamiya Y, Okada M, Hirako M, Takada N, Kawaguchi M: Primary hypomagnesemia caused by isolated magnesium malabsorption: atypical case in adult. Intern Med. 1999 Mar;38(3):261-5. [PubMed:10337938 ]
| | Bartter Syndrome, Type 1, Antenatal |
|---|
- Adachi M, Asakura Y, Sato Y, Tajima T, Nakajima T, Yamamoto T, Fujieda K: Novel SLC12A1 (NKCC2) mutations in two families with Bartter syndrome type 1. Endocr J. 2007 Dec;54(6):1003-7. Epub 2007 Nov 12. [PubMed:17998760 ]
| | Bartter Syndrome, Type 2, Antenatal |
|---|
- Chan WK, To KF, Tong JH, Law CW: Paradoxical hypertension and salt wasting in Type II Bartter syndrome. Clin Kidney J. 2012 Jun;5(3):217-20. doi: 10.1093/ckj/sfs026. Epub 2012 Mar 29. [PubMed:26069767 ]
| | Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency |
|---|
- Guven A, Polat S: Testicular Adrenal Rest Tumor in Two Brothers with a Novel Mutation in the 3-Beta-Hydroxysteroid Dehydrogenase-2 Gene. J Clin Res Pediatr Endocrinol. 2017 Mar 1;9(1):85-90. doi: 10.4274/jcrpe.3306. Epub 2016 Jul 29. [PubMed:27476613 ]
| | Bartter Syndrome, Type 3 |
|---|
- Seys E, Andrini O, Keck M, Mansour-Hendili L, Courand PY, Simian C, Deschenes G, Kwon T, Bertholet-Thomas A, Bobrie G, Borde JS, Bourdat-Michel G, Decramer S, Cailliez M, Krug P, Cozette P, Delbet JD, Dubourg L, Chaveau D, Fila M, Jourde-Chiche N, Knebelmann B, Lavocat MP, Lemoine S, Djeddi D, Llanas B, Louillet F, Merieau E, Mileva M, Mota-Vieira L, Mousson C, Nobili F, Novo R, Roussey-Kesler G, Vrillon I, Walsh SB, Teulon J, Blanchard A, Vargas-Poussou R: Clinical and Genetic Spectrum of Bartter Syndrome Type 3. J Am Soc Nephrol. 2017 Aug;28(8):2540-2552. doi: 10.1681/ASN.2016101057. Epub 2017 Apr 5. [PubMed:28381550 ]
| | Bartter Syndrome, Type 4B, Neonatal, With Sensorineural Deafness |
|---|
- Nozu K, Inagaki T, Fu XJ, Nozu Y, Kaito H, Kanda K, Sekine T, Igarashi T, Nakanishi K, Yoshikawa N, Iijima K, Matsuo M: Molecular analysis of digenic inheritance in Bartter syndrome with sensorineural deafness. J Med Genet. 2008 Mar;45(3):182-6. doi: 10.1136/jmg.2007.052944. [PubMed:18310267 ]
| | Congenital secretory diarrhea |
|---|
- Muller T, Wijmenga C, Phillips AD, Janecke A, Houwen RH, Fischer H, Ellemunter H, Fruhwirth M, Offner F, Hofer S, Muller W, Booth IW, Heinz-Erian P: Congenital sodium diarrhea is an autosomal recessive disorder of sodium/proton exchange but unrelated to known candidate genes. Gastroenterology. 2000 Dec;119(6):1506-13. [PubMed:11113072 ]
| | Congenital chloride diarrhea |
|---|
- Lubani MM, Doudin KI, Sharda DC, Shaltout AA, al-Shab TS, Abdul Al YK, Said MA, Salhi MM, Ahmed SA: Congenital chloride diarrhoea in Kuwaiti children. Eur J Pediatr. 1989 Jan;148(4):333-6. [PubMed:2651131 ]
| | Bartter Syndrome, Type 5, Antenatal, Transient |
|---|
- Laghmani K, Beck BB, Yang SS, Seaayfan E, Wenzel A, Reusch B, Vitzthum H, Priem D, Demaretz S, Bergmann K, Duin LK, Gobel H, Mache C, Thiele H, Bartram MP, Dombret C, Altmuller J, Nurnberg P, Benzing T, Levtchenko E, Seyberth HW, Klaus G, Yigit G, Lin SH, Timmer A, de Koning TJ, Scherjon SA, Schlingmann KP, Bertrand MJ, Rinschen MM, de Backer O, Konrad M, Komhoff M: Polyhydramnios, Transient Antenatal Bartter's Syndrome, and MAGED2 Mutations. N Engl J Med. 2016 May 12;374(19):1853-63. doi: 10.1056/NEJMoa1507629. Epub 2016 Apr 27. [PubMed:27120771 ]
| | Hyperdibasic aminoaciduria I |
|---|
- Whelan DT, Scriver CR: Hyperdibasicaminoaciduria: an inherited disorder of amino acid transport. Pediatr Res. 1968 Nov;2(6):525-34. [PubMed:5727921 ]
|
|
|---|